YAHOO FINANCE CHARTBOOK 44 charts that explain markets and the economy right now Frankfurt - Delayed Quote • EUR Vaxart, Inc. (NB11.F) Follow Compare 0.6700 -0.0310 (-4.42%) At close: 8:00:26 AM GMT+1 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for NB11.F 1D 5D -3.39% 1M 15.42% 3M 1.52% 6M 22.82% YTD -0.74% 1Y -10.07% 5Y 17.54% All -99.82% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: NB11.F View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors Vaxart Highlights Progress of COVID-19, Norovirus and Influenza Programs Vaxart Announces Favorable DSMB Review of Sentinel Cohort from COVID-19 Phase 2b Clinical Trial Vaxart project agreement change ups funding for oral COVID vaccine candidate Top Midday Gainers Vaxart Completes Enrollment of Sentinel Cohort in Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Vaxart Third Quarter 2024 Earnings: Beats Expectations Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform and ... VAXART, INC. (VXRT) Reports Q3 Loss, Tops Revenue Estimates Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results